Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...

healthcare.philips.com
from healthcare.philips.com More from this publisher
19.02.2013 Views

CMS-1403-FC and improve the quality and value of care provided to Medicare beneficiaries. We do not believe that beneficiaries will experience drug access issues as a result of the changes with respect to Part B drugs and discontinuation of payment for preadministration services associated with IVIG. As explained in more detail subsequently in this section, the regulatory provisions may affect beneficiary liability in some cases. Most changes aggregate in beneficiary liability due to a particular provision would be a function of the coinsurance (20 percent if applicable for the particular provision after the beneficiary has met the deductible). Beneficiary liability would also be impacted by the effect of the aggregate cost (savings) of the provision on the standard calculation of the Medicare Part B premium rate (generally 25 percent of the provision's cost or savings). In 2009, total cost sharing (coinsurance and deductible) per Part B enrollee associated with PFS services is estimated to be $468. In addition, the portion of the 2009 standard monthly Part B premium attributable to PFS services is estimated to be $40.10. To illustrate this point, as shown in Table 47, the 2008 national payment amount in the nonfacility setting for CPT code 99203 (Office/outpatient visit, new), is $91.03 1090

CMS-1403-FC which means that in 2008 a beneficiary is responsible for 20 percent of this amount, or $18. Based on this rule, the 2009 national payment amount in the nonfacility setting for CPT code 99203, as shown in Table 47, is $91.97 which means that, in 2009, the beneficiary coinsurance for this service would be $18.39. Policies discussed in this rule that do affect overall spending, such as the additions to the list of codes that are subject to the MPPR for diagnostic imaging, would similarly impact beneficiaries’ coinsurance. W. Accounting Statement As required by OMB Circular A-4 (available at http://www.whitehouse.gov/omb/circulars/a004/a-4.pdf), in Table 53, we have prepared an accounting statement showing the classification of the expenditures associated with this final rule with comment period. This estimate includes the incurred benefit impact associated with the estimated CY 2009 PFS update based on the 2008 Trustees Report baseline, as well as certain MIPPA provisions. All estimated impacts are classified as transfers. 1091

<strong>CMS</strong>-1403-FC<br />

which means that in 2008 a beneficiary is responsible for<br />

20 percent of this amount, or $18. Based on this rule, the<br />

2009 national payment amount in the nonfacility setting for<br />

CPT code 99203, as shown in Table 47, is $91.97 which means<br />

that, in 2009, the beneficiary coinsurance for this service<br />

would be $18.39.<br />

Policies discussed in this rule that do affect overall<br />

spending, such as the additions to the list of codes that<br />

are subject to the MPPR for diagnostic imaging, would<br />

similarly impact beneficiaries’ coinsurance.<br />

W. Accounting Statement<br />

As required by OMB Circular A-4 (available at<br />

http://www.whitehouse.gov/omb/circulars/a004/a-4.pdf), in<br />

Table 53, we have prepared an accounting statement showing<br />

the classification of the expenditures associated with this<br />

final rule with comment period. <strong>This</strong> estimate includes the<br />

incurred benefit impact associated with the estimated<br />

CY 2009 PFS update based on the 2008 Trustees Report<br />

baseline, as well as certain MIPPA provisions. All<br />

estimated impacts are classified as transfers.<br />

1091

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!